Physician profile
Santhi Mekala
NPI 1730292368
$672.98
in general payments reported to CMS, 2019-2025
12 companies · $33.94 in 2025
The $33.94 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $55.77 · 2021: $122 · 2022: $121 · 2024: $15.57 · 2025: $33.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $147.23 | 2019-2022 | |
| Lilly USA, LLC | $102.12 | 2019-2022 | |
| Cardiovascular Systems INC. | $99.88 | 2019 | |
| Novo Nordisk INC | $61.20 | 2019-2021 | |
| Tactile Systems Technology INC | $49.51 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Pfizer INC. | $46.76 | 2020-2022 | |
| Abbott Laboratories | $37.62 | 2021 | |
| Amarin Pharma, INC. | $34.88 | 2019-2021 | |
| Abbvie INC. | $34.02 | 2019 | |
| Glaxosmithkline, LLC. | $26.29 | 2019 | |
| Alexion Pharmaceuticals, INC. | $20.41 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Santhi Mekala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.